developer, editor
60,576
edits
Changes
Jump to navigation
Jump to search
'''"Misdeeds by pharmaceutical industry"'''
'''29-11-2006'''
"New medicines are often tested on people in developing countries in an unethical manner. The Wemos Foundation in Amsterdam, the Netherlands, finds it scandalous that the pharmaceutical industry exploits the weak position of people in developing countries. A new report from the Dutch Centre for Research on Multinational Corporations (SOMO) documents no fewer than 22 known cases in which the rights of trial subjects have been violated.
The report was released on Friday, 17 November during an event held to mark the silver jubilee of the Wemos Foundation. Liesbeth van der Kruit took such politicians as Diederik Samsom (PvdA) and Kees Vendrik(GroenLinks) to task about this issue during the Grote Verkiezingsshow (the Great Election Show). The report describes tests that involved various well-known pharmaceutical companies such as Novo Nordisk, Pfizer, Johnson & Johnson, Novartis, AstraZeneca and GlaxoSmithKline."<ref>[http://somo.nl/news-en/misdeeds-by-pharmaceutical-industry/?searchterm=novartis "Report from the Dutch Centre for Research on Multinational Corporations on unfair pharmaceutical trial practices"]</ref>
'''"Compulsory licensing “a last mechanism,” says Thai Health Minister"'''
'''August, 2008.''' "Thailand’s new Public Health Minister, Chawarat Charnveerakul, has said that imposing compulsory licensing (CL) is “the last mechanism” that the government would use “to help the poor get access to life-saving drugs at a fair price."
"First, we have to negotiate with drug firms to reduce the price of their drugs. If they do not agree with us we will then impose compulsory licensing for expensive drugs to save our patients’ lives," said Mr Chawarat, who was appointed to his post this month in a cabinet reshuffle. He added that his Ministry had not revoked the CL policy as a way of obtaining essential drugs, but retained it as “a key mechanism” in negotiating for lower prices."<ref>[http://pharmatimes.co.uk/Forums/forums/t/2065.aspx "Compulsory licensing on pharmaceutical drugs in Thailand"]</ref>
'''"Malaria campaigners hopeful on drugs pricing deal"'''
'''Septemeber, 2008.''' "Anti-malaria campaigners are confident that a deal can be reached with pharmaceuticals groups to cut the cost of new drugs needed to fight a disease estimated to kill more than 1 million people a year.
Negotiations are being held with several big drugs makers as part of a wider drive to bring the cost of so-called artemisinin-based combination therapies (ACTs) down to the level of the older, but now ineffective, chloroquinine treatments.
"I am very hopeful that this first stage, the negotiations, will produce results,"Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria told reporters in Paris on Tuesday."<ref>[http://www.alertnet.org/thenews/newsdesk/L9420228.htm "Malaria campaigners hopeful on drugs pricing deal"]</ref>
SW: →Human Rights: shift cut and pasted material to talk
===Human Rights===
===Environment ===
